Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Glaxo Buoyed As Drug Gets Recommended For Approval

Fri, 21st Feb 2014 11:40

LONDON (Alliance News) - The following is a summary of top news stories xxxxday.
----------
COMPANIES
----------
Royal Dutch Shell has reached a binding agreement to sell its Australia downstream businesses, excluding Aviation, to Dutch-owned oil trader Vitol for a total of about USD2.6 billion. The sale covers Shell's Geelong Refinery and 870-site retail business, and includes its bulk fuels, bitumen, chemicals and part of its lubricants businesses in Australia. The sale also includes a brand license arrangement and an exclusive distributor arrangement in Australia for Shell Lubricants.
----------
Royal Bank of Scotland Group is preparing a dramatic retrenchment that would see it become a much smaller UK retail and commercial bank, a move that is expected to see staff numbers slashed by at least 30,000 in the coming years, the Financial Times reported, citing people familiar with the bank's plans.
----------
Legal & General has expanded its investment management arm in the world's largest economy by buying Atlanta-based Global Index Advisors Inc for up to USD50.4 million. The British insurer had wanted to expand its international investment management operations to help drive growth, and the Global Index deal, its first acquisition in the US, means its US investment management unit now has proforma assets of over USD50 billion. It said the acquisition will give it scale in the USD6 trillion US defined contribution market. It will pay USD30.75 million initially, a further USD1.5 million over the two years following completion, and up to USD18.15 million more over the three years following completion, subject to the performance of Global Index and its ability to grow assets.
----------
GlaxoSmithKline's Incruse, a treatment for chronic obstructive pulmonary disease, had been recommended for marketing authorisation by the European Medicines Agency's committee for Medical Products for Human Use, a key step in getting approval for the drug.
----------
Rolls-Royce Holdings has won a USD182.7 million extension on its contract to provide support for the US Air Force's C-130J transport plane fleet. The British company looks after the AE 2100 engines on the planes.
----------
Tullow Oil said the operator of the Langlitinden prospect in Norway, in which it has a 15% stake, had failed to find any oil. The well on the site will be plugged and abandoned.
----------
Millennium & Copthorne Hotels Group reported higher revenues and profits for 2013, solely due to a one-off profit boost from the Glyndebourne property development in Singapore at the end of the fourth quarter, and said its room refurbishment programme would continue to weigh on its results this year. It reported a pretax profit of GBP167.7 million for the fourth quarter of 2013, up from only GBP54.2 million a year earlier, and recorded a pretax profit of GBP263.6 million for the year as a whole, compared with a profit of GBP171.3 million in 2012.
----------
Informa pledged to deliver further growth in adjusted earnings per share in 2014, as it reported improved revenue and pretax profit for 2013 in the first set of results under new Chief Executive Stephen Carter. The new CEO said a key objective for Informa in 2014 will be managing the transition in leadership as smoothly and effectively as possible. He set out two major challenges for Informa: addressing the shift in technology happening in Informa's market, and returning the company's Business Intelligence division to growth.
----------
IP Group shares jumped after the firm announced that portfolio company Xeros Ltd intends to float on AIM in March to raise funds to bring its cleaning product to the laundry market.
----------
MARKETS
----------
The FTSE 100 is on track to post its sixth consecutive daily rise, as weaker-than-expected UK retail sales and public finances data failed to dent the recent market positivity.
----------
FTSE 100: Up 0.2% at 6,826.97
FTSE 250: Up 0.2% at 16,400.34
AIM ALL-SHARE: Up 0.02% at 883.10
----------
The pound trimmed its early losses against other major currencies in European deals on Friday, despite a fall in UK retail sales in January.
----------
GBP-USD: Up at USD1.6674
EUR-USD: Down at USD1.3707

GOLD: Up at USD1,321.22 per ounce
OIL (Brent): Down at USD109.96 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
British retail sales declined more than expected in January due to a notable decrease in food store sales. Including automotive fuel, retail sales fell 1.5% month-on-month in January, which was the first decline in three months, the Office for National Statistics said. Economists were expecting sales to fall 1% after posting a 2.5% rise in December. Sales excluding automotive fuel, also decreased by 1.5% in January versus 2.7% increase a month ago. Sales were forecast to drop 1.2%.
Food store sales slipped 3.4% from December, while non-food store sales gained 0.4% in January.
----------
The UK's budget surplus declined unexpectedly in January from the same period of last year. Public sector net borrowing excluding temporary effects of financial interventions was -GBP 4.7 billion in January compared to -GBP 6 billion last year, the Office for National Statistics said. The surplus was expected to rise to GBP 8 billion. The January figure excludes GBP 3.8 billion asset purchase facility transfer.
----------
Confidence among British residents regarding the value of their homes increased to the record high in February, data from a survey by Knight Frank and Markit Economics revealed. The headline house price sentiment index, which measures households' views of the current value of their houses, climbed to 60.7 in February, hitting the highest level since the survey began. The index has now stayed above the no-change 50 mark, which separates growth from contraction, for the eleventh successive month. Property owners in every region of the UK perceived that the value of their home rose in February, led by London, data showed.
----------
Multinationals that shift revenue around the world to pare their tax bill will be in the firing line at this weekend's meeting in Sydney of global finance chiefs, Australia's top economics minister said.
Joe Hockey said that "where you earn the money you pay the tax" and that the G20 finance chiefs meeting he is hosting is "where the rubber hits the road on these issues."
----------
Negotiators from the EU and Russia have agreed with Ukrainian President Viktor Yanukovych and the opposition on a solution to the political crisis, the president's office says. The deal was due to be signed on Friday at 1000 GMT. A senior pro-government lawmaker, Oleksandr Yefremov, said the deal includes an early presidential election in December and a vote on constitutional change in September. However, other participants in the eight-hour talks, which lasted until the early morning, urged caution as unknown gunmen in Kiev opened fire on police guarding the parliament building, the Interior Ministry said during a week that has seen at least 77 people die in unrest between anti-government protesters and security forces in Ukraine's capital.
---------
Italy's prime ministerial designate, Matteo Renzi, was due to present his government team on Friday, a day earlier than expected. Renzi, the outgoing mayor of Florence and leader of the centre-left Democratic Party, has been negotiating a coalition pact with the New Centre Right party of Angelino Alfano and smaller centrist and leftists groupings.
---------
A draft UN Security Council resolution on humanitarian aid access in war-torn Syria has been finalized and will be put to vote Saturday morning, said Gary Quinlan, Australian ambassador to the UN. The draft backed by Western and Arab states calls for ending violence against civilians, allowing humanitarian aid into Syria and also makes provision for the use of force in the case of non-compliance, according to a copy of the draft obtained by dpa. The text calls for lifting the siege of several areas, including Old City Homs, Aleppo and Damascus, to allow civilians to leave and get access to food and medical help.
----------
UN Secretary General Ban Ki-moon presented a six-point action plan to the UN Security Council Thursday, saying immediate measures are needed to stop violence in the Central African Republic.
"The international community must act decisively now to prevent any further worsening of the situation and to respond to the dire needs of the country's people," Ban told the council. The secretary general appealed for 3,000 additional troops, increased funding, political support to establish a functioning government in the country and assistance to get the peace process underway.
----------
Libyans voted on Thursday to elected members of an assembly that will draft a new constitution, which many hope will avert violence between rival militias and armed factions. Turnout was reported to be low. Many Libyans are disillusioned with politics three years after the outbreak of the revolt that ended with the caputre and killing of Moamer Gaddafi.
----------
Iran is complying with obligations under an interim agreement with six world powers by curbing its nuclear activities and allowing more intrusive inspections, the UN nuclear watchdog said in its second positive assessment. The International Atomic Energy Agency issued its report hours after Iran and the six nations agreed to an intensive schedule of talks to reach a comprehensive agreement and resolve the standoff over Tehran's nuclear programme.
----------
China urged the US to cancel a planned meeting Friday between US President Barack Obama and the Dalai Lama at the White House. The meeting would cause "serious damage" to ties between the two countries and amount to interference in China's domestic affairs, Foreign Ministry spokeswoman Hua Chunying said.
----------
North and South Korean families divided since the Korean War in the 1950s met again Friday in the latest set of reunions, a media report said. Eighty-two selected South Koreans accompanied by 58 family members saw 180 relatives from the North at the coastal resort of Mount Kumgang in North Korea, the South's Yonhap News Agency said.
----------
Copyright © 2014 Alliance News Limited. All Rights Reserved.


More News
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.